Altimmune (ALT) had the highest return between March 17, 2017 and October 8, 2017 by a small-cap US stock, returning 22,699,900%.
| ASSET | DATE | % RETURN |
|---|---|---|
Altimmune (ALT) | 3/17/2017 - 10/8/2017 | 22,699,900% |
HIVE Digital Technologies (HIVE) | 3/17/2017 - 10/8/2017 | 1,637.5% |
Fennec Pharmaceuticals (FENC) | 3/17/2017 - 10/8/2017 | 411.35% |
Global Industrial (GIC) | 3/17/2017 - 10/8/2017 | 240.96% |
Verastem (VSTM) | 3/17/2017 - 10/8/2017 | 217.81% |
Evotec SE ADR (EVO) | 3/17/2017 - 10/8/2017 | 191.79% |
Puma Biotechnology (PBYI) | 3/17/2017 - 10/8/2017 | 179.08% |
Intrepid Potash (IPI) | 3/17/2017 - 10/8/2017 | 177.14% |
Ridgepost Capital (RPC) | 3/17/2017 - 10/8/2017 | 173.26% |
BioLife Solutions (BLFS) | 3/17/2017 - 10/8/2017 | 159.01% |
Novocure (NVCR) | 3/17/2017 - 10/8/2017 | 147.26% |
MannKind (MNKD) | 3/17/2017 - 10/8/2017 | 143% |
Nutex Health (NUTX) | 3/17/2017 - 10/8/2017 | 138.1% |
Ballard Power Systems (BLDP) | 3/17/2017 - 10/8/2017 | 137.21% |
QuinStreet (QNST) | 3/17/2017 - 10/8/2017 | 132.82% |
Arbutus Biopharma (ABUS) | 3/17/2017 - 10/8/2017 | 130.65% |
Cryoport (CYRX) | 3/17/2017 - 10/8/2017 | 128.46% |
Palvella Therapeutics (PVLA) | 3/17/2017 - 10/8/2017 | 125.72% |
UroGen Pharma (URGN) | 3/17/2017 - 10/8/2017 | 121.08% |
Intellia Therapeutics (NTLA) | 3/17/2017 - 10/8/2017 | 117.05% |
Lendingtree (TREE) | 3/17/2017 - 10/8/2017 | 109.25% |
National Research (NRC) | 3/17/2017 - 10/8/2017 | 107.8% |
Lightwave Logic (LWLG) | 3/17/2017 - 10/8/2017 | 105.93% |
Quidel (QDEL) | 3/17/2017 - 10/8/2017 | 101.41% |
Johnson Outdoors (JOUT) | 3/17/2017 - 10/8/2017 | 99.29% |
Small-cap stocks are treated as having a market cap between $300M and $2B.